Bangs Laboratories Introduces UltraMod Microsphere Technology

The company is presenting the technology during the ADLM Lecture Series on July 28 at 12:30 p.m. in Exhibit Hall Theater 2.

The session, titled “Engineering a Better Bead: Introducing UltraMod Technology for Accelerated Development, Scaling, and Validation of Fit-for-Purpose Microspheres,” focuses on improving the development of microsphere reagents for clinical and laboratory applications. UltraMod is designed to address the time and variability associated with optimizing bead-based reagents for individual diagnostic assays.

The platform uses a modular development workflow that allows assay developers to systematically adjust microsphere characteristics, including magnetic separation speed, surface properties, and particle size. These attributes can be tailored to specific assay requirements while maintaining consistency between manufacturing lots.

During the presentation, Bangs Laboratories is sharing case studies showing how UltraMod’s modular design principles can be applied to ongoing reagent development programs. Attendees are also learning how the platform’s scaling strategies can be incorporated into existing workflows to reduce optimization cycles and shorten assay validation timelines.

The session additionally examines a validation framework aligned with regulatory expectations to help developers evaluate and select bead-based reagent platforms. The approach is intended to provide a more predictable path from early-stage microsphere optimization through manufacturing scale-up and validation.

Designed for assay developers, laboratory scientists, and diagnostics research and development professionals, the presentation highlights practical strategies for reducing reagent variability and supporting robust assay performance across research and clinical diagnostic settings. Bangs Laboratories provides custom particle engineering, reagent development, and microsphere and nanosphere products for diagnostic, biotechnology, and research applications.